Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Chemotherapy-Induced Thrombocytopenia”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Not applicableStudy completedNCT05688306
What this trial is testing

To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Liaoning Cancer Hospital & Institute 3,494
Testing effectiveness (Phase 2)Looking for participantsNCT07043894
What this trial is testing

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients

Who this might be right for
Solid TumorsHematological TumorChildren+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Testing effectiveness (Phase 2)Ended earlyNCT03622931
What this trial is testing

Patients With Relapsed Ovarian Cancer (2nd and 3rd Line) Treated With Chemotherapy According to AGO Guidelines

Who this might be right for
Ovarian Cancer
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 21
Testing effectiveness (Phase 2)Looking for participantsNCT07492693
What this trial is testing

Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors

Who this might be right for
Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors
Changhai Hospital 40
Post-approval studies (Phase 4)UnknownNCT03633019
What this trial is testing

High-dose Use of rhTPO in CIT Patients

Who this might be right for
Thrombocytopenia
First Affiliated Hospital Xi'an Jiaotong University 50
Testing effectiveness (Phase 2)Ended earlyNCT01676961
What this trial is testing

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+2 more
NYU Langone Health 5
Very early researchLooking for participantsNCT07048249
What this trial is testing

Single Arm Romiplostim to Prevent CIT

Who this might be right for
Ewings SarcomaChemotherapy Induced Thrombocytopenia
Children's Hospital Medical Center, Cincinnati 26
Large-scale testing (Phase 3)WithdrawnNCT03343847
What this trial is testing

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma.

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Amgen
Large-scale testing (Phase 3)Study completedNCT03362177
What this trial is testing

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Amgen 165
Large-scale testing (Phase 3)Active Not RecruitingNCT03937154
What this trial is testing

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

Who this might be right for
Chemotherapy-induced Thrombocytopenia
Amgen 145
Early research (Phase 1)Active Not RecruitingNCT05426369
What this trial is testing

A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT)

Who this might be right for
Chemotherapy-induced Thrombocytopenia (CIT)
Sichuan Clover Biopharmaceuticals, Inc. 36
Early research (Phase 1)Looking for participantsNCT06245746
What this trial is testing

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaNeutropeniaAnemia+3 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 9
Testing effectiveness (Phase 2)Study completedNCT05963334
What this trial is testing

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Advanced Epithelial Ovarian Cancer
Cairo University 49
Testing effectiveness (Phase 2)Looking for participantsNCT07586826
What this trial is testing

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

Who this might be right for
Persistent Isolated Chemotherapy-Induced ThrombocytopeniaChemotherapy-Induced ThrombocytopeniaGynecologic Cancers+7 more
Peking University People's Hospital 220
Early research (Phase 1)Study completedNCT06521931
What this trial is testing

PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients

Who this might be right for
Thrombocytopenia
Chongqing Peg-Bio Biopharm Co., Ltd. 24
Not applicableStudy completedNCT03567798
What this trial is testing

Thrombocytopenia Induced by Chemotherapy

Who this might be right for
Thrombocytopenia
Socrates School Of Health 60
Post-approval studies (Phase 4)Ended earlyNCT02032134
What this trial is testing

Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia

Who this might be right for
ThrombocytopeniaPrimary Thrombocytopenia,UnspecifiedThrombocytopenia Chemotherapy Induced
Napolitano Mariasanta 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07771881
What this trial is testing

Romiplostim N01 for Injection for Secondary Prophylaxis of CIT in Breast Cancer

Who this might be right for
Thrombocytopenia Chemotherapy Induced
Fudan University 53
Not applicableUnknownNCT02344979
What this trial is testing

The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC

Who this might be right for
Thrombocytopenia
Shenyang Sunshine Pharmaceutical Co., LTD. 120
Large-scale testing (Phase 3)Looking for participantsNCT07286032
What this trial is testing

Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia

Who this might be right for
Patients With Chemotherapy-Induced Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 150
Next Page